(Burlington, N.C.) Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a genetic test to detect the presence of a single polymorphism within the IL-28B gene that has been reported to help predict a person’s response to certain hepatitis C virus (HCV) therapies. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions is pleased to announce that the Optiform™ compound optimization platform, a novel, solid-state and highly-automated analysis platform for salt, crystal-form, and co-crystal screening, developed and refined over the past ten years within GlaxoSmithKline (GSK) will now be broadly available to early development scientists for the first time.  The technology has resulted in faster and more material-efficient development workflows, making it easier to bring new drugs to market faster. The Optiform™ compound optimization platform has been applied to more than 500 compounds, spanning from early stage lead compounds through launched products.  GSK has entered into an agreement with Catalent to utilize the Optiform™ platform to support its internal screening activities. The deal between Catalent and GSK was brokered by SR One, GSK’s corporate venture fund. (more…)

(Research Triangle Park, N.C.) Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, has been invited by the Taiwan Biotech Organization to lead a one-day workshop on GMP Bioassay Validation and GLP Immunogenicity Method Development on July 28, 2010. Dr. Menendez will also be delivering a podium presentation titled “Effective Transfer of Complex Biological Method” at the Key Technology Forum in Protein Drug Development, July 29, 2010. The Forum will focus on upstream process development, downstream process development, analytical and bioassay method development, formulation development and manufacturing, facility construction, and quality assurance and regulatory issues. (more…)

(Research Triangle Park, N.C.) Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be leading an interactive pre-conference workshop titled, “Immunogenicity Programs: Not Just Another Box to Check” at the 6th Annual Global Proteins Summit in London, UK. The workshop will be held on June 22 at 12:30pm. The Summit brings together experts from all over the world, presenting the latest developments in protein therapeutics, cell culture expression and immunogenicity. (more…)

(Research Triangle Park, N.C.) Gregory T. Bleck, PhD., Senior Director of Cell Line Engineering for Catalent Pharma Solutions, will lead a webinar on the characteristics of effective mammalian cell line generation process for bio-pharmaceutical production on May 25, 2010 at 2pm EDT. To register for this complimentary webinar please visit: https://www2.gotomeeting.com/register/853525658. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions’ industry experts will deliver scientific poster presentations this month at the 2010 AAPS National Biotechnology Conference, May 16-19 in San Francisco, California. This week of educational programming is dedicated to advancing health through innovations in biotherapeutics. Catalent is a sustaining sponsor of the 2010 AAPS National Biotechnology Conference. (more…)

(Research Triangle Park, N.C.) Richard Martin, CFO of Entegrion, joined forty-four distinguished professionals as Triangle Business Leader and BDO Seidman LLP’s 2009 Top CFO’s of the Triangle. The 2009 Top CFO winners were selected out of 140 nominations from the categories of Financial Services, Infrastructure, Real Estate, Tech & Telecom, Business Services, and Products & Services. The Triangle’s Top CFOs were recognized at the Briar Creek Country Club held on the evening of October 13th.  Many of the area’s top CFO’s were in attendance and the keynote speaker for the event was Frank G. Paci, Executive VP of Business Operations, CFO of The Pantry, Inc. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions will host a free Webinar featuring Senior Manager, Wei Pan, Ph.D. RAC and Kathy Waddle, Director, Stability QC Biology.  The one-hour Webinar will cover stability studies as a critical part of the drug development process and the vital role they play for drug product marketing approval.  The Webinar, titled “Stability Studies in Pharmaceutical Development,” will be held on Tuesday, November 20, 2009 at 2 p.m. (EST). To register for the Webinar please visit: https://www2.gotomeeting.com/register/280747146. (more…)

(Research Triangle Park, N.C.) NCTechNews, North Carolina’s technology news source, is accepting nominations from businesses and organizations for its “Biotech Story of the Year” top ten list for 2009. The list of stories will provide NCTechNews readers with detailed information about each top ten nominee and their newsworthy milestones contributing to the life sciences community in North Carolina. Every qualifying organization or business submitting a nomination will appear on the final list compilation to be published on NCTechNews, along with a hot link to their individual websites, with the top ten headlining a feature article and press release announcing the final list. (more…)

(Research Triangle Park, N.C.) Laboratory equipment represents an elevated risk of product safety dangers. CertifiGroup has a special new program to help manufacturers, designers and equipment owners for this high-tech category. In many cases, non-certified laboratory equipment is never identified as a high risk category in the workplace. Scientists and facility owners assume the manufacturers have considered electrical and product safety merely because the equipment is often expensive. The CertifiGroup laboratory equipment evaluation team has been collecting data on the hazards for operators and facilities, and the results are startling. (more…)

(Research Triangle Park, N.C.) Early phase drug development consulting firm ClinPharm Consulting and 20-year pharmaceutical industry veteran Eric Nelson, Ph.D. have announced a strategic partnership to expand upon their core offerings for emerging pharmaceutical and biotechnology companies. (more…)

(Research Triangle Park, N.C.) Entegrion, Inc., a privately owned life sciences product development company specializing in technologies for hemorrhage control, resuscitation, and tissue repair, was a winner in the 2009 New Product & Technology Awards. This national program, presented by the Mature Market Resource Center, a national clearinghouse for the senior market, is the first awards program of its kind to recognize the most innovative products and services for older adults and their families. (more…)